Benzodiazepine receptor function in anxiety disorders
Malizia, A.L.; Coupland, N.J.; Nutt, D.J.
Advances in Biochemical Psychopharmacology 48: 115-133
1995
ISSN/ISBN: 0065-2229 PMID: 7653322 Document Number: 442969
Document emailed within 1 workday
Related Documents
Riemann, D. 1996: Anxiety disorders. Diagnosis and therapy in family practice. 1: Anxiety reactions--psychiatric disorders and anxiety--anxiety disorders Fortschritte der Medizin 114(33): 457-459Dilday, J.K. 1991: Anxiety disorders: diagnosis and treatment. How to prevent complications of benzodiazepine dependency and withdrawal Journal of the Arkansas Medical Society 88(4): 171-173
Olsen, R.W.; Stauber, G.B.; King, R.G.; Yang, J.; Dilber, A. 1986: Structure and function of the barbiturate-modulated benzodiazepine/GABA receptor protein complex Advances in Biochemical Psychopharmacology 41: 21-32
Lucki, I. 1996: Serotonin receptor specificity in anxiety disorders Journal of Clinical Psychiatry 57(Suppl): 5-10
Gallager, D.W.; Wilson, M.A. 1988: Chronic benzodiazepine agonist exposure: comparison of electrophysiological changes by brain region and benzodiazepine receptor ligand Advances in Biochemical Psychopharmacology 45: 325-336
Squires, R.F.; Klepner, C.A.; Benson, D.I. 1980: Multiple benzodiazepine receptor complexes: some benzodiazepine recognition sites are coupled to GABA receptors and ionophores Advances in Biochemical Psychopharmacology 21: 285-293
Salzman, C.; Goldenberg, I.; Bruce, S.E.; Keller, M.B. 2001: Pharmacologic treatment of anxiety disorders in 1989 versus 1996: results from the Harvard/Brown anxiety disorders research program Journal of Clinical Psychiatry 62(3): 149-152
Miller, L.G.; Greenblatt, D.J.; Roy, R.B.; Summer, W.R.; Shader, R.I. 1988: Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function Journal of Pharmacology and Experimental Therapeutics 246(1): 177-182
Fehr, C.; Grintschuk, N.; Szegedi, A.; Anghelescu, I.; Klawe, C.; Singer, P.; Hiemke, C.; Dahmen, N. 2000: The HTR1B 861G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy Psychiatry Research 97(1): 1-10
Knoflach, F.; Drescher, U.; Scheurer, L.; Malherbe, P.; Mohler, H. 1993: Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes Journal of Pharmacology and Experimental Therapeutics 266(1): 385-391
Motak, E. 1987: The DSM IIi classification of anxiety disorders in the light of psychological models of anxiety Psychiatria Polska 21(6): 533-539
Chevalier, A.; Bonenfant, S.; Picot, M.C.; Chastang, J.F.; Luce, D. 1996: Occupational factors of anxiety and depressive disorders in the French National Electricity and Gas Company. The Anxiety-Depression Group Journal of Occupational and Environmental Medicine 38(11): 1098-1107
Coplan, J.D.; Rozenboym, A.V.; Fulton, S.L.; Panthangi, V.; Tang, J.; Thiramangalakdi, L.; Perera, T.D.; Liu, Y.; Kamran, H.; Owens, M.J.; Nemeroff, C.B.; Rosenblum, L.A.; Kral, J.G.; Salciccioli, L.; Lazar, J. 2018: Reduced left ventricular dimension and function following early life stress: a thrifty phenotype hypothesis engendering risk for mood and anxiety disorders Neurobiology of Stress 8: 202-210
Belzung, C. 2001: Rodent models of anxiety-like behaviors: are they predictive for compounds acting via non-benzodiazepine mechanisms? Current Opinion in Investigational Drugs 2(8): 1108-1111
Simonelli, V.M. 1975: Evaluation of the efficacy of a new perparation containing benzodiazepine in drops in anxiety-erethism syndrome of the child La Pediatria 83(4): 762-772
Kalin, N.H. 2003: Nonhuman primate studies of fear, anxiety, and temperament and the role of benzodiazepine receptors and GABA systems Journal of Clinical Psychiatry 64(Suppl 3): 41-44
Petracca, A.; Michelini, S.; Perugi, G.; Cassano, G.B. 1991: Benzodiazepine withdrawal syndrome. Problems of differential diagnosis against depression, panic attacks and generalized anxiety La Clinica Terapeutica 137(3): 191-197
Anzini, M.; Cappelli, A.; Vomero, S.; Botta, M.; Cagnotto, A. 1990: 5-HT and benzodiazepine receptor ligands. III. Synthesis and receptor affinities of 1,2,4-triazolo[4',3':1,6]pyridazino[4,5-b]quinoline and 2,3-dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinoline-1-one derivatives Farmaco 45(11): 1169-1179
Ballenger, J.C.; McDonald, S.; Noyes, R.; Rickels, K.; Sussman, N.; Woods, S.; Patin, J.; Singer, J. 1991: The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder Psychopharmacology Bulletin 27(2): 171-179
Jalenques, I.; Coudert, A.J. 1992: A limit of anxiety disorders. Obsessive-compulsive disorders in children and adolescents Archives Francaises de Pediatrie 49(8): 735-739